Analysis of the RNASEL gene in familial and sporadic prostate cancer

Liang Wang, Shannon K. McDonnell, David A. Elkins, Susan L. Slager, Eric Christensen, Angela F. Marks, Julie M. Cunningham, Brett J. Peterson, Steven J. Jacobsen, James R. Cerhan, Michael L. Blute, Daniel J. Schaid, Stephen N. Thibodeau

Research output: Contribution to journalArticlepeer-review

88 Scopus citations


The RNASEL gene on chromosome 1q25 was recently identified as a candidate gene for hereditary prostate cancer (PC). To confirm these findings, we screened 326 patients from 163 families with familial PC for potential germline mutations, by use of conformation-sensitive gel electrophoresis, followed by direct sequence analysis. A total of six variants were identified, including one intronic and five exonic changes (three missense and two silent alterations). There were no unequivocal pathogenic changes. To further test for potential associations between genes and increased risk for disease, the three missense polymorphisms (Ile97Leu, Arg462Gln, and Glu541Asp) were genotyped in 438 patients with familial PC and in 510 population-based control subjects. Association testing revealed no significant differences between patients and control subjects for either the Leu97 variant (X2 trend test = 1.42; P =. 23) or the Asp541 variant (X2 = 1.52; P =. 22). However, significant differences were detected for the Arg462Gln genotypes (X2 = 5.20; P =. 02; odds ratio [OR] = 0.54; 95% confidence interval [CI] 0.32-0.91) when the genotype Gln/Gln was compared with Arg/Arg. In subset analyses, associations were also observed in the younger group (age at diagnosis ≤64 years) (P =. 0008; OR = 0.29; 95% CI = 0.13-0.66), in node-negative patients (P =. 01; OR = 0.48; 95% CI 0.27-0.84), patients with stage T1/T2 disease (P =. 008; OR = 0.39; 95% CI 0.2-0.75), and patients with low-grade disease (P =. 01; OR = 0.40; 95% CI 0.20-0.78). To evaluate whether this variant was also associated with sporadic PC, we genotyped an additional 499 patients with sporadic PC. Differences in frequency were not detected between patients with sporadic disease and control subjects. However, the same association was observed between patients with familial disease and patients with sporadic disease for the entire group (X2 = 4.82; P =. 03), as well as in the subset analyses. These results suggest that polymorphic changes within the RNASEL gene may be associated with increased risk of familial but not sporadic PC.

Original languageEnglish (US)
Pages (from-to)116-123
Number of pages8
JournalAmerican journal of human genetics
Issue number1
StatePublished - Jul 2002

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Analysis of the RNASEL gene in familial and sporadic prostate cancer'. Together they form a unique fingerprint.

Cite this